iShares Biotechnology ETF $IBB Shares Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 38.1% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 417,500 shares of the financial services provider’s stock after acquiring an additional 115,194 shares during the period. iShares Biotechnology ETF comprises 0.6% of Jefferies Financial Group Inc.’s portfolio, making the stock its 12th biggest position. Jefferies Financial Group Inc.’s holdings in iShares Biotechnology ETF were worth $87,896,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. IFP Advisors Inc boosted its holdings in iShares Biotechnology ETF by 39.3% during the second quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after purchasing an additional 14,115 shares during the last quarter. Security National Bank of Sioux City Iowa IA grew its position in iShares Biotechnology ETF by 31.8% in the second quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock valued at $2,318,000 after purchasing an additional 2,939 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in iShares Biotechnology ETF by 64.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after buying an additional 39,760 shares during the last quarter. Navellier & Associates Inc. acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $531,000. Finally, Tidal Investments LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $1,512,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $218.14 on Thursday. The company’s 50-day moving average price is $208.98 and its two-hundred day moving average price is $186.54. iShares Biotechnology ETF has a one year low of $159.68 and a one year high of $222.29.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were issued a $0.0112 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.0%. The ex-dividend date was Tuesday, September 15th. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.